Progyny IncNASDAQ:PGNY
- LAST PRICE15.6300
- TODAY'S CHANGE (%)0.4800 (3.1683%)
- Bid / Lots15.6200/ 2
- Ask / Lots15.6400/ 8
- Open / Previous Close15.0400 / 15.1500
- Day Range
- 52 Week Range
- Volume258,921
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PGNY |
|---|---|---|
| 09:32 ET | 10699 | 15.09 |
| 09:33 ET | 4281 | 15 |
| 09:35 ET | 3589 | 15.12 |
| 09:37 ET | 16072 | 15.16 |
| 09:39 ET | 8583 | 15.17 |
| 09:42 ET | 2714 | 15.24 |
| 09:44 ET | 1176 | 15.25 |
| 09:46 ET | 900 | 15.265 |
| 09:48 ET | 300 | 15.28 |
| 09:50 ET | 6535 | 15.35 |
| 09:51 ET | 10263 | 15.39 |
| 09:53 ET | 6361 | 15.38 |
| 09:55 ET | 3147 | 15.43 |
| 09:57 ET | 4000 | 15.395 |
| 10:00 ET | 500 | 15.405 |
| 10:02 ET | 4629 | 15.41 |
| 10:04 ET | 3518 | 15.42 |
| 10:06 ET | 2952 | 15.44 |
| 10:08 ET | 1717 | 15.475 |
| 10:09 ET | 1751 | 15.42 |
| 10:11 ET | 7576 | 15.515 |
| 10:13 ET | 700 | 15.495 |
| 10:15 ET | 1390 | 15.52 |
| 10:18 ET | 1690 | 15.525 |
| 10:20 ET | 2261 | 15.51 |
| 10:22 ET | 2398 | 15.475 |
| 10:24 ET | 2835 | 15.47 |
| 10:26 ET | 4054 | 15.48 |
| 10:27 ET | 3434 | 15.46 |
| 10:29 ET | 1694 | 15.47 |
| 10:31 ET | 9636 | 15.48 |
| 10:33 ET | 3300 | 15.48 |
| 10:36 ET | 4506 | 15.49 |
| 10:38 ET | 12191 | 15.4901 |
| 10:40 ET | 6150 | 15.5 |
| 10:42 ET | 1600 | 15.5 |
| 10:44 ET | 2257 | 15.5 |
| 10:45 ET | 1000 | 15.52 |
| 10:47 ET | 2453 | 15.56 |
| 10:49 ET | 568 | 15.57 |
| 10:51 ET | 100 | 15.58 |
| 10:54 ET | 10964 | 15.53 |
| 10:56 ET | 2320 | 15.54 |
| 10:58 ET | 1832 | 15.53 |
| 11:00 ET | 1664 | 15.53 |
| 11:02 ET | 1143 | 15.555 |
| 11:03 ET | 2323 | 15.56 |
| 11:05 ET | 3823 | 15.63 |
| 11:07 ET | 2411 | 15.63 |
| 11:09 ET | 5039 | 15.65 |
| 11:12 ET | 3370 | 15.63 |
Yesterday
Nov 2, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progyny, Inc. - PGNY, from 11:00AM ET on Saturday Nov 02, 2024 by Dow Jones
11:00AM ET on Saturday Nov 02, 2024 by Dow Jones
Oct 31, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progyny, Inc. - PGNY, from 8:01PM ET on Thursday Oct 31, 2024 by Dow Jones
8:01PM ET on Thursday Oct 31, 2024 by Dow Jones
Oct 29, 2024
Progyny, Inc. Announces Details for Its Third Quarter 2024 Results Report, from 2:00PM ET on Tuesday Oct 29, 2024 by Dow Jones
2:00PM ET on Tuesday Oct 29, 2024 by Dow JonesSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progyny, Inc. - PGNY, from 12:05PM ET on Tuesday Oct 29, 2024 by Dow Jones
12:05PM ET on Tuesday Oct 29, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Progyny Inc | 1.4B | 24.9x | --- |
Clover Health Investments Corp | 2.2B | -16.3x | --- |
Alignment Healthcare Inc | 2.5B | -17.3x | --- |
Interpace Biosciences Inc | 10.7M | 4.5x | --- |
Molina Healthcare Inc | 18.9B | 16.7x | +12.22% |
Humana Inc | 30.8B | 23.2x | +9.96% |
Company Information
Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.4 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
Contact Information
- Headquarters
- 1359 BroadwayNEW YORK, NY, United States 10018
- Phone
- 212-888-3124
- Fax
- 302-636-5454
Executives
- Executive Chairman of the Board
- David Schlanger
- President
- Michael Sturmer
- Chief Executive Officer, Director
- Peter Anevski
- Chief Financial Officer
- Mark Livingston
- Executive Vice President, General Counsel, Company Secretary
- Allison Swartz
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.4B |
|---|---|
Revenue (TTM) | $1.1B |
Shares Outstanding | 90.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.36 |
EPS | $0.63 |
Book Value | $5.74 |
P/E Ratio | 24.9x |
Price/Sales (TTM) | 1.2 |
Price/Cash Flow (TTM) | 20.9x |
Operating Margin | 6.28% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
